by Eric Christianson | Jan 26, 2025 | Endocrine Medication and Disease State Clinical Pearls
Type II diabetes is a complicated disease state that often requires a combination of medications to control. However, some combinations of antidiabetes medications, such as sulfonylureas and basal insulin, may lead to unintended adverse effects. In this article, we...
by Eric Christianson | Jan 12, 2025 | Endocrine Medication and Disease State Clinical Pearls
Treating patients with type II diabetes often requires an array of medications to control blood sugar and manage various comorbidities. Understanding possible drug-drug and drug-disease interactions between medications is extremely important for optimizing medication...
by Eric Christianson | Jan 5, 2025 | Gastrointestinal Medication and Disease State Clinical Pearls
I’ve had some wonderful guest posts in the past and I couldn’t help but notice this awesome post on LinkedIn from a fellow pharmacist! April Oliveros is the author of this quick hitter on “Does Every Patient On Anticoagulation Need a PPI?” You...
by Eric Christianson | Dec 29, 2024 | Endocrine Medication and Disease State Clinical Pearls
Reducing diabetes medications in geriatric patients with low A1c involves careful consideration of the risks and benefits of continued intensive glycemic control. In older adults, particularly those with multiple comorbidities, frailty, or limited life expectancy,...
by Eric Christianson | Dec 25, 2024 | Neurology, Pain, and Musculoskeletal Case Studies
In this case scenario, I lay out a situation where cyclobenzaprine causes confusion. A 76-year-old female has a history of pain issues including RA, back pain, and knee pain. She is currently a resident at a long-term care facility. Her medications include: Lisinopril...
